Lonazep 1mg Tablet MD contains Clonazepam, a benzodiazepine derivative with potent anticonvulsant, anxiolytic, muscle relaxant, and sedative properties. It is primarily indicated for the management of seizure disorders, including absence seizures, myoclonic seizures, and Lennox-Gastaut syndrome, as well as for the treatment of panic disorder with or without agoraphobia. Clonazepam acts by enhancing the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the central nervous system, thereby stabilizing neuronal membranes and reducing excessive electrical activity. Lonazep 1mg is administered orally and should be used under strict medical supervision due to the risk of dependence, tolerance, and withdrawal symptoms associated with long-term benzodiazepine use. Dosage should be individualized based on patient response, age, and clinical condition, with gradual titration recommended to minimize adverse effects such as drowsiness, dizziness, cognitive impairment, and ataxia. Caution is advised in patients with hepatic or renal impairment, respiratory disorders, or a history of substance abuse. Concomitant use with other central nervous system depressants may potentiate sedative effects. Lonazep 1mg Tablet MD should be stored in a cool, dry place, away from direct sunlight and out of reach of children. Regular monitoring and adherence to prescribed dosage are essential for safe and effective therapy.